{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:58:16Z","timestamp":1788872296354,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000927","name":"Prostate Cancer Foundation of Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000927","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bone.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T04:00:37Z","timestamp":1392177637000},"page":"121-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis"],"prefix":"10.1016","volume":"63","author":[{"given":"Shirly","family":"Sieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Taubenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie L.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar W.","family":"Hutmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.02.001_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bone.2014.02.001_bb0010","series-title":"World Health Organization","article-title":"Cancer","author":"WHO","year":"2006"},{"key":"10.1016\/j.bone.2014.02.001_bb0015","author":"SEER"},{"key":"10.1016\/j.bone.2014.02.001_bb0025","series-title":"Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells","first-page":"1860","author":"Blaszczyk","year":"2004"},{"issue":"18","key":"10.1016\/j.bone.2014.02.001_bb0030","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-05-1891","article-title":"Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism","volume":"65","author":"Dai","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bone.2014.02.001_bb0035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.bjc.6600115","article-title":"Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases","volume":"86","author":"Bryden","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2014.02.001_bb0040","series-title":"High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?","first-page":"6250s","author":"Bruland","year":"2006"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.bone.2014.02.001_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.suronc.2006.10.002","article-title":"The metastatic cascade in prostate cancer","volume":"15","author":"Arya","year":"2006","journal-title":"Surg Oncol"},{"key":"10.1016\/j.bone.2014.02.001_bb0055","series-title":"Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer","first-page":"2","author":"Stewart","year":"2004"},{"issue":"2","key":"10.1016\/j.bone.2014.02.001_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.044","article-title":"Osteotropic cancers: from primary tumor to bone","volume":"273","author":"Buijs","year":"2008","journal-title":"Cancer Lett"},{"issue":"17","key":"10.1016\/j.bone.2014.02.001_bb0065","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","article-title":"Prostate cancer cells promote osteoblastic bone metastases through Wnts","volume":"65","author":"Hall","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pros.20678","article-title":"RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes","volume":"68","author":"Armstrong","year":"2008","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.bone.2014.02.001_bb0075","first-page":"1509","article-title":"TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction","volume":"29","author":"Yuen","year":"2008"},{"issue":"5","key":"10.1016\/j.bone.2014.02.001_bb0080","first-page":"849","article-title":"Identification of a unique set of genes altered during cell\u2013cell contact in an in vitro model of prostate cancer bone metastasis","volume":"17","author":"Wang","year":"2006","journal-title":"Int J Mol Med"},{"issue":"8","key":"10.1016\/j.bone.2014.02.001_bb0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10585-009-9289-0","article-title":"Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts","volume":"26","author":"Zhang","year":"2009","journal-title":"Clinical and Experimental Metastasis"},{"issue":"3","key":"10.1016\/j.bone.2014.02.001_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","article-title":"Tensional homeostasis and the malignant phenotype","volume":"8","author":"Paszek","year":"2005","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bone.2014.02.001_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrm1890","article-title":"Local force and geometry sensing regulate cell functions","volume":"7","author":"Vogel","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.bone.2014.02.001_bb0100","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bone.2014.02.001_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1039\/c0ib00095g","article-title":"Biophysical regulation of tumor cell invasion: moving beyond matrix stiffness","volume":"3","author":"Pathak","year":"2010","journal-title":"Integr Biol"},{"issue":"3","key":"10.1016\/j.bone.2014.02.001_bb0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2010.04.004","article-title":"Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors","volume":"20","author":"Cukierman","year":"2010","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.bone.2014.02.001_bb0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/pros.20465","article-title":"Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer","volume":"67","author":"Gao","year":"2007","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00157682","article-title":"Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin","volume":"14","author":"Kostenuik","year":"1996","journal-title":"Clin Exp Metastasis"},{"issue":"31","key":"10.1016\/j.bone.2014.02.001_bb0125","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1016\/j.biomaterials.2010.06.055","article-title":"Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment","volume":"31","author":"Reichert","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1476-4598-12-112","article-title":"Bone-stromal cells up-regulate tumourigenic markers in a tumour\u2013stromal 3D model of prostate cancer","volume":"12","author":"Windus","year":"2013","journal-title":"Mol Cancer"},{"issue":"4","key":"10.1016\/j.bone.2014.02.001_bb0135","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.biomaterials.2011.10.046","article-title":"Three-dimensional cancer-bone metastasis model using ex-vivo co-cultures of live calvarial bones and cancer cells","volume":"33","author":"Curtin","year":"2012","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bone.2014.02.001_bb0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4161\/org.6.3.12041","article-title":"Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model","volume":"6","author":"Sieh","year":"2010","journal-title":"Organogenesis"},{"issue":"21","key":"10.1016\/j.bone.2014.02.001_bb0150","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1158\/0008-5472.CAN-07-2483","article-title":"Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model","volume":"67","author":"Moreau","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.02.001_bb0155","series-title":"A three-dimensional osteogenic tissue model for the study of metastatic tumor cell interactions with bone","first-page":"0008","author":"Mastro","year":"2009"},{"key":"10.1016\/j.bone.2014.02.001_bb0160","series-title":"Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis","first-page":"9996","author":"Sung","year":"2008"},{"key":"10.1016\/j.bone.2014.02.001_bb0165","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jbmr.1875","article-title":"Delineating breast cancer cell interactions with engineered bone microenvironments","author":"Taubenberger","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.bone.2014.02.001_bb0170","series-title":"Cranioplasty after trephination using a novel biodegradable burr hole cover: technical case report","first-page":"ONS-E176","author":"Schantz","year":"2006"},{"key":"10.1016\/j.bone.2014.02.001_bb0175","series-title":"Androgen receptor and invasion in prostate cancer","first-page":"1128","author":"Hara","year":"2008"},{"issue":"10","key":"10.1016\/j.bone.2014.02.001_bb0180","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1158\/0008-5472.CAN-05-3082","article-title":"Evolution of the androgen receptor pathway during progression of prostate cancer","volume":"66","author":"Hendriksen","year":"2006","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.bone.2014.02.001_bb0185","first-page":"2507","article-title":"Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue","volume":"3","author":"Joseph","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.bone.2014.02.001_bb0190","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1158\/0008-5472.CAN-06-3332","article-title":"Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer","volume":"67","author":"Mostaghel","year":"2007","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.bone.2014.02.001_bb0195","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.bone.2014.02.001_bb0200","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1021\/bm070228f","article-title":"Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions","volume":"8","author":"Ehrbar","year":"2007","journal-title":"Biomacromolecules"},{"issue":"26","key":"10.1016\/j.bone.2014.02.001_bb0205","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1016\/j.biomaterials.2007.03.027","article-title":"Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering","volume":"28","author":"Ehrbar","year":"2007","journal-title":"Biomaterials"},{"issue":"32","key":"10.1016\/j.bone.2014.02.001_bb0210","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1016\/j.biomaterials.2010.07.046","article-title":"The effect of matrix characteristics on fibroblast proliferation in 3D gels","volume":"31","author":"Bott","year":"2010","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.bone.2014.02.001_bb0215","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.biomaterials.2006.09.032","article-title":"Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts","volume":"28","author":"Zhou","year":"2007","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.bone.2014.02.001_bb0220","doi-asserted-by":"crossref","first-page":"e40217","DOI":"10.1371\/journal.pone.0040217","article-title":"Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment","volume":"7","author":"Sieh","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bone.2014.02.001_bb0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1046-2023(03)00155-5","article-title":"Normalization of cDNA microarray data","volume":"31","author":"Smyth","year":"2003","journal-title":"Methods"},{"issue":"8a","key":"10.1016\/j.bone.2014.02.001_bb0230","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1582-4934.2009.00853.x","article-title":"Translating tissue engineering technology platforms into cancer research","volume":"13","author":"Hutmacher","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bone.2010.05.035","article-title":"Metastatic bone disease: role of transcription factors and future targets","volume":"48","author":"Pratap","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2014.02.001_bb0240","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/onc.2009.389","article-title":"Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions","volume":"29","author":"Akech","year":"2010","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bone.2014.02.001_bb0245","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jcb.22463","article-title":"The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells","volume":"109","author":"van der Deen","year":"2010","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.bone.2014.02.001_bb0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S8756-3282(98)00080-5","article-title":"Expression and distribution of transforming growth factor-\u03b2 isoforms and their signaling receptors in growing human bone","volume":"23","author":"Horner","year":"1998","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bone.2014.02.001_bb0255","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-[beta]1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0260","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.20674","article-title":"Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A: cholesterol acyltransferase (ACAT)","volume":"68","author":"Locke","year":"2008","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0265","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00223-012-9613-6","article-title":"Targeted disruption of TGFBI in mice reveals its role in regulating bone mass and bone size through periosteal bone formation","volume":"91","author":"Yu","year":"2012","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/0008-5472.CAN-08-1648","article-title":"TGFBI deficiency predisposes mice to spontaneous tumor development","volume":"69","author":"Zhang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.02.001_bb0275","article-title":"Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells","volume":"2012","author":"Ye","year":"2012","journal-title":"Urol Oncol"},{"issue":"13","key":"10.1016\/j.bone.2014.02.001_bb0280","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/pros.20988","article-title":"The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma","volume":"69","author":"Tsunoda","year":"2009","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0285","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00648.2007","article-title":"Insulin-like growth factor-binding proteins and bone metabolism","volume":"294","author":"Conover","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.cellbio.16.1.191","article-title":"Bone development","volume":"16","author":"Olsen","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"8","key":"10.1016\/j.bone.2014.02.001_bb0295","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10585-007-9118-2","article-title":"TGF-beta and BMP7 interactions in tumour progression and bone metastasis","volume":"24","author":"Buijs","year":"2007","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"10.1016\/j.bone.2014.02.001_bb0300","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.urolonc.2009.09.016","article-title":"Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models","volume":"29","author":"Li","year":"2011","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.bone.2014.02.001_bb0305","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrurol.2013.146","article-title":"Cell mates: paracrine and stromal targets for prostate cancer therapy","volume":"10","author":"Sluka","year":"2013","journal-title":"Nat Rev Urol"},{"issue":"9","key":"10.1016\/j.bone.2014.02.001_bb0310","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1074\/jbc.M108255200","article-title":"Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways","volume":"277","author":"Ueda","year":"2002","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.bone.2014.02.001_bb0315","first-page":"4640","article-title":"Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor","volume":"58","author":"Hobisch","year":"1998","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.bone.2014.02.001_bb0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H","article-title":"Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer","volume":"41","author":"Drachenberg","year":"1999","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.bone.2014.02.001_bb0325","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1200\/JCO.1998.16.10.3398","article-title":"Apples and oranges: building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trials","volume":"16","author":"Dawson","year":"1998","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.bone.2014.02.001_bb0330","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1158\/0008-5472.CAN-07-5997","article-title":"Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer","volume":"68","author":"Locke","year":"2008","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.bone.2014.02.001_bb0335","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1158\/0008-5472.CAN-04-3448","article-title":"Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcdb.2009.11.016","article-title":"Tumor stroma co-evolution in prostate cancer progression and metastasis","volume":"21","author":"Josson","year":"2010","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.bone.2014.02.001_bb0345","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13547500701676019","article-title":"TGF-beta signalling-related markers in cancer patients with bone metastasis","volume":"13","author":"Baselga","year":"2008","journal-title":"Biomarkers"},{"issue":"13","key":"10.1016\/j.bone.2014.02.001_bb0350","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/pros.21361","article-title":"Blockade of transforming growth factor-beta (TGF\u03b2) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line","volume":"71","author":"Mishra","year":"2011","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0090-4295(96)00426-8","article-title":"Transforming growth factor beta as a clinical biomarker for prostate cancer","volume":"49","author":"Perry","year":"1997","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.bone.2014.02.001_bb0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3","article-title":"Transforming growth factor \u03b21 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer","volume":"37","author":"Wikstr\u00f6m","year":"1998","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.bone.2014.02.001_bb0365","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.2001.19.11.2856","article-title":"Preoperative plasma levels of transforming growth factor beta1 (TGF-\u03b21) strongly predict progression in patients undergoing radical prostatectomy","volume":"19","author":"Shariat","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T01:18:24Z","timestamp":1716513504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":71,"alternative-id":["S8756328214000386"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.02.001","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}